Micro/nano technology for extracellular vesicle isolation and towards non-invasive pancreatic cancer diagnosis
Objective
Primary Objective To assess the micro/nano technology platform for isolation of plasma-derived EVs.
Secondary Objectives To assess the detection of KRAS mutations from EV-derived DNA isolated from the plasma of patients with metastatic PC. To investigate KRAS mutations in EV-derived DNA isolated from the plasma of patients with PC at different stages.